FLII and Sepsis: Given the observed decline in se-Flii levels in sepsis and sepsis-related ARDS, it may be worthwhile developing a multiparametric approach that integrates both clinical variable assessment and biomarker measurements (e.g., Flii and other markers [PCT, GSN, Gc]) to potentially enhance the diagnostic and predictive performance of standard clinical variables.